from Wiktionary, Creative Commons Attribution/Share-Alike License

  • n. Any lipid, such as sphingomyelin, that is derived from sphingosine or one of its derivatives


Sorry, no etymologies found.


  • Gamma-tocopherol or combinations of vitamin E forms induce cell death in human prostate cancer cells by interrupting sphingolipid synthesis.

    Craig Cooper: The Real Facts About Vitamin E and Prostate Cancer

  • In particular we propose that the well-known clusters of Ashkenazi genetic diseases, the sphingolipid cluster and the DNA repair cluster in particular, increase intelligence in heterozygotes.

    Vacuity of ID: Dembski Channeling Colbert? - The Panda's Thumb

  • Unlike many speculations, it makes a testable prediction: that people who carry one of the sphingolipid or other Ashkenazic disease mutations should do better than average on I.Q. tests.

    Nicholas Wade in New York Times on the Cochran-Hardy-Harpending Theory of Ashkenazi IQ

  • The sphingolipid-storage diseases, Tay-Sachs, Gaucher's and Niemann-Pick, all involve extra growth and branching of the protuberances that connect nerve cells together.

    Archive 2005-05-29

  • Dr. Slatkin, though favoring a founder effect over all, said he agreed with the Utah team that this would not account for the cluster of sphingolipid diseases.

    Archive 2005-06-05

  • The authors "make pretty much all of the classic mistakes in interpreting heritability," said Dr. Andrew Clark, a population geneticist at Cornell University, and the argument that the sphingolipid gene variants are associated with intelligence, he said, is "far-fetched."

    Archive 2005-06-05

  • As to how the disease mutations might affect intelligence, the Utah researchers cite evidence that the sphingolipid disorders promote the growth and interconnection of brain cells.

    Archive 2005-06-05

  • Lpath has also obtained issued claims on sphingolipid targets e.g., receptors and signaling sphingolipids and methods for using such targets in drug-discovery screening efforts.

  • The new U.S. patent No. 7,862,812 claims methods of decreasing an immune response and treating diseases or conditions characterized by an aberrant, excessive, or undesired immune response using an antibody that inhibits a sphingolipid or sphingolipid metabolite, such as S1P.

  • Lpath's intellectual-property portfolio includes compositions of matter that specifically bind to sphingolipids and sphingolipid metabolites.


Log in or sign up to get involved in the conversation. It's quick and easy.